W Bradford Middlekauff - Net Worth and Insider Trading

W Bradford Middlekauff Net Worth

The estimated net worth of W Bradford Middlekauff is at least $1,910 dollars as of 2024-05-05. W Bradford Middlekauff is the Senior VP, GC and Secretary of PDS Biotechnology Corp and owns about 500 shares of PDS Biotechnology Corp (PDSB) stock worth over $1,910. Details can be seen in W Bradford Middlekauff's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that W Bradford Middlekauff has not made any transactions after 2016-08-08 and currently still holds the listed stock(s).

Transaction Summary of W Bradford Middlekauff

To

W Bradford Middlekauff Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, W Bradford Middlekauff owns 4 companies in total, including Immunovant Inc (IMVTU) , PDS Biotechnology Corp (PDSB) , and Immunovant Inc (IMVT) among others .

Click here to see the complete history of W Bradford Middlekauff’s form 4 insider trades.

Insider Ownership Summary of W Bradford Middlekauff

Ticker Comapny Transaction Date Type of Owner
IMVTU Immunovant Inc 2020-05-15 General Counsel
PDSB PDS Biotechnology Corp 2016-08-08 Senior VP & GC and Secretary
IMVT Immunovant Inc 2019-12-18 General Counsel
2023-10-19 CBO & GC and Secretary

W Bradford Middlekauff Latest Holdings Summary

W Bradford Middlekauff currently owns a total of 1 stock. W Bradford Middlekauff owns 500 shares of PDS Biotechnology Corp (PDSB) as of August 8, 2016, with a value of $1,910.

Latest Holdings of W Bradford Middlekauff

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PDSB PDS Biotechnology Corp 2016-08-08 500 3.82 1,910

Holding Weightings of W Bradford Middlekauff


W Bradford Middlekauff Form 4 Trading Tracker

According to the SEC Form 4 filings, W Bradford Middlekauff has made a total of 0 transactions in PDS Biotechnology Corp (PDSB) over the past 5 years. The most-recent trade in PDS Biotechnology Corp is the acquisition of 500 shares on August 8, 2016, which cost W Bradford Middlekauff around $94,800.

Insider Trading History of W Bradford Middlekauff

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

W Bradford Middlekauff Trading Performance

GuruFocus tracks the stock performance after each of W Bradford Middlekauff's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by W Bradford Middlekauff is 7.56%. GuruFocus also compares W Bradford Middlekauff's trading performance to market benchmark return within the same time period. The performance of stocks bought by W Bradford Middlekauff within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how W Bradford Middlekauff's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of W Bradford Middlekauff

Average Return

Average return per transaction

Outperforming Transactions

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 12.03
Relative Return to S&P 500(%) 12.01

W Bradford Middlekauff Ownership Network

Ownership Network List of W Bradford Middlekauff

No Data

Ownership Network Relation of W Bradford Middlekauff


W Bradford Middlekauff Owned Company Details

What does Immunovant Inc do?

Who are the key executives at Immunovant Inc?

W Bradford Middlekauff is the General Counsel of Immunovant Inc. Other key executives at Immunovant Inc include 10 percent owner Roivant Sciences Ltd. , Chief Dev. & Tech. Officer Julia G. Butchko , and Chief Scientific Officer Michael James Elliott .

Immunovant Inc (IMVTU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Immunovant Inc (IMVTU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Immunovant Inc (IMVTU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Immunovant Inc (IMVTU)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Immunovant Inc Insider Transactions

No Available Data

W Bradford Middlekauff Mailing Address

Above is the net worth, insider trading, and ownership report for W Bradford Middlekauff. You might contact W Bradford Middlekauff via mailing address: 200 Connell Drive, Suite 1600, Berkeley Heights Nj 07922.

Discussions on W Bradford Middlekauff

No discussions yet.